YPEL3, a p53-Regulated Gene that Induces Cellular Senescence

被引:47
|
作者
Kelley, Kevin D. [1 ]
Miller, Kelly R. [1 ]
Todd, Amber [1 ]
Kelley, Amy R. [1 ]
Tuttle, Rebecca [2 ]
Berberich, Steven J. [1 ]
机构
[1] Wright State Univ, Dept Biochem & Mol Biol, Dayton, OH 45435 USA
[2] Wright State Univ, Dept Surg, Dayton, OH 45435 USA
关键词
ONCOGENIC RAS; TARGET GENES; IN-VIVO; P53; CELLS; RESTORATION; FIBROBLASTS; APOPTOSIS; FAMILY;
D O I
10.1158/0008-5472.CAN-09-3219
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cellular senescence, the limited ability of cultured normal cells to divide, can result from cellular damage triggered through oncogene activation (premature senescence) or the loss of telomeres following successive rounds of DNA replication (replicative senescence). Although both processes require a functional p53 signaling pathway, relevant downstream p53 targets have been difficult to identify. Discovery of senescence activators is important because induction of tumor cell senescence may represent a therapeutic approach for the treatment of cancer. In microarray studies in which p53 was reactivated in MCF7 cells, we discovered that Yippee-like-3 (YPEL3), a member of a recently discovered family of putative zinc finger motif coding genes consisting of YPEL1-5, is a p53-regulated gene. YPEL3 expression induced by DNA damage leads to p53 recruitment to a cis-acting DNA response element located near the human YPEL3 promoter. Physiologic induction of YPEL3 results in a substantial decrease in cell viability associated with an increase in cellular senescence. Through the use of RNAi and H-ras induction of cellular senescence, we show that YPEL3 activates cellular senescence downstream of p53. Consistent with its growth suppressive activity, YPEL3 gene expression is repressed in ovarian tumor samples. One mechanism of YPEL3 downregulation in ovarian tumor cell lines seems to be hypermethylation of a CpG island upstream of the YPEL3 promoter. We believe these findings point to YPEL3 being a novel tumor suppressor, which upon induction triggers a permanent growth arrest in human tumor and normal cells. Cancer Res; 70(9); 3566-75. (C) 2010 AACR.
引用
收藏
页码:3566 / 3575
页数:10
相关论文
共 50 条
  • [21] Tumour suppression by p53: the importance of apoptosis and cellular senescence
    Zuckerman, Valentina
    Wolyniec, Kamil
    Sionov, Ronit V.
    Haupt, Sue
    Haupt, Ygal
    JOURNAL OF PATHOLOGY, 2009, 219 (01) : 3 - 15
  • [22] Down-expression of poly(ADP-ribose) polymerase in p53-regulated pancreatic cancer cells
    Hou, Zhenyu
    Cui, Yunfeng
    Xing, Huizhi
    Mu, Xiaoyan
    ONCOLOGY LETTERS, 2018, 15 (02) : 1943 - 1948
  • [23] The Rho GTPase RhoE is a p53-regulated candidate tumor suppressor in cancer cells
    Zhu, Yajie
    Zhou, Jitao
    Xia, Hongwei
    Chen, Xiangzheng
    Qiu, Meng
    Huang, Juan
    Liu, Surui
    Tang, Qiulin
    Lang, Nan
    Liu, Zhen
    Liu, Ming
    Zheng, Yi
    Bi, Feng
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2014, 44 (03) : 896 - 904
  • [24] Manganese Superoxide Dismutase Is a p53-Regulated Gene That Switches Cancers between Early and Advanced Stages
    Dhar, Sanjit K.
    Tangpong, Jitbanjong
    Chaiswing, Luksana
    Oberley, Terry D.
    St Clair, Daret K.
    CANCER RESEARCH, 2011, 71 (21) : 6684 - 6695
  • [25] p53-regulated lncRNAs in cancers: from proliferation and metastasis to therapy
    Yang, Kaixin
    Xiao, Yinan
    Zhong, Linghui
    Zhang, Wenyang
    Wang, Peng
    Ren, Yaru
    Shi, Lei
    CANCER GENE THERAPY, 2023, 30 (11) : 1456 - 1470
  • [26] Induction of p53-regulated genes in lung cancer cells: implications of the mechanism for adenoviral p53-mediated apoptosis
    Gu, J
    Zhang, LD
    Swisher, SG
    Liu, JS
    Roth, JA
    Fang, BL
    ONCOGENE, 2004, 23 (06) : 1300 - 1307
  • [27] Implication of p53-dependent cellular senescence related gene, TARSH in tumor suppression
    Wakoh, Takeshi
    Uekawa, Natsuko
    Terauchi, Kunihiko
    Sugimoto, Masataka
    Ishigami, Akihito
    Shirnada, Jun-ichi
    Maruyama, Mitsuo
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2009, 380 (04) : 807 - 812
  • [28] Coagulation factor V in breast cancer: a p53-regulated tumor suppressor and predictive marker for treatment response to chemotherapy
    Lind, Sara Marie
    Sletten, Marit
    Hellenes, Mona
    Mathelier, Anthony
    Tekpli, Xavier
    Tinholt, Mari
    Iversen, Nina
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2024, 22 (06) : 1569 - 1582
  • [29] Genome-wide analysis of p53-regulated transcription in Myc-driven lymphomas
    Tonelli, C.
    Morelli, M. J.
    Sabo, A.
    Verrecchia, A.
    Rotta, L.
    Capra, T.
    Bianchi, S.
    Campaner, S.
    Amati, B.
    ONCOGENE, 2017, 36 (21) : 2921 - 2929
  • [30] Downregulation of splicing factor SRSF3 induces p53β, an alternatively spliced isoform of p53 that promotes cellular senescence
    Tang, Y.
    Horikawa, I.
    Ajiro, M.
    Robles, A. I.
    Fujita, K.
    Mondal, A. M.
    Stauffer, J. K.
    Zheng, Z-M
    Harris, C. C.
    ONCOGENE, 2013, 32 (22) : 2792 - 2798